September 16, 2022The Adderall shortage reported earlier this summer spurred by labor constraints at a plant run by drug manufacturer Teva Pharmaceuticals is creating a trickle-down effect that is making generic forms of the ADHD medication difficult to find and fill across the United States.
According to the American Society of Health-System Pharmacists (ASHP), three additional drug manufacturers — who together with Teva provide one-half of the U.S.
supply of generic Adderall — are now reporting supply shortfalls. Because Adderall (dextroamphetamine-amphetamine, or amphetamine salts) is a Schedule 2 controlled substance, the federal government limits the amount that any one company is allowed to manufacture.
Read more on additudemag.com